Y-mAbs Therapeutics
YMAB
YMAB
42 hedge funds and large institutions have $176M invested in Y-mAbs Therapeutics in 2018 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
+5
Holders Change %
+13.51%
% of All Funds
0.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
17
Increased
10
Reduced
10
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Fidelity Investments
Boston,
Massachusetts
|
$33.1M |
| 2 |
2
BlackRock
New York
|
$6.95M |
| 3 |
3
AllianceBernstein
Nashville,
Tennessee
|
$11.3M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$5.23M |
| 5 |
5
Geode Capital Management
Boston,
Massachusetts
|
$1.59M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Point72 Asset Management
Stamford,
Connecticut
| – | -$133K | -5,000 | Closed |
|
|
PHK
52
Point72 Hong Kong
Hong Kong
| – | -$86K | -3,252 | Closed |
|
|
RCM
53
Riverhead Capital Management
Wilmington,
Delaware
| – | -$63K | -2,380 | Closed |
|
|
CSS
54
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$55K | -2,082 | Closed |
|
|
MIM
55
Monashee Investment Management
Boston,
Massachusetts
| – | -$1.8M | – | – |
|